MA 07.01 Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial
| Autor: | Mok, T., Peters, S., Camidge, D.R., Gadgeel, S., Ignatius Ou, S., Kim, D., Dziadziuszko, R., De Marinis, F., Sangha, R., Zeaiter, A., Noe, J., Nueesch, E., Liu, T., Loftin, I., Williams, C., Shaw, A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1826-S1826 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|